What are the corresponding antihypertensive drug classes for the following medications: Chlorthalidone, Candesartan, Amlodipine, Ramipril, Carvedilol, and Verapamil?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antihypertensive Drug Classes and Their Corresponding Medications

Chlorthalidone is a thiazide-type diuretic, Candesartan is an angiotensin receptor blocker (ARB), Amlodipine is a dihydropyridine calcium channel blocker, Ramipril is an ACE inhibitor, Carvedilol is a beta blocker, and Verapamil is a non-dihydropyridine calcium channel blocker.

Detailed Classification

1. Chlorthalidone - Thiazide-type Diuretic

  • Chlorthalidone belongs to the class of thiazide-type diuretics, which are primary agents for hypertension management 1
  • It has a longer half-life and more potent blood pressure-lowering effect than hydrochlorothiazide 2
  • Typical dosing range is 12.5-25 mg daily 1
  • It has demonstrated significant cardiovascular event reduction in major clinical trials 2, 3

2. Candesartan - Angiotensin Receptor Blocker (ARB)

  • Candesartan cilexetil is classified as an angiotensin receptor blocker (ARB) 1
  • It blocks the effects of angiotensin II at receptor sites 4
  • Typical dosing range is 8-32 mg once daily 1
  • It's commonly used in combination therapy, particularly with diuretics or calcium channel blockers 4, 5

3. Amlodipine - Dihydropyridine Calcium Channel Blocker

  • Amlodipine is a dihydropyridine calcium channel blocker 1
  • It has a long duration of action allowing for once-daily dosing 6
  • Typical dosing range is 2.5-10 mg daily 1
  • It's effective in both hypertension and coronary artery disease 6

4. Ramipril - ACE Inhibitor

  • Ramipril belongs to the class of angiotensin-converting enzyme (ACE) inhibitors 1
  • It prevents the conversion of angiotensin I to angiotensin II 1
  • Typical dosing range is 2.5-20 mg daily, administered once or twice daily 1
  • It has demonstrated cardiovascular protection in high-risk patients 1

5. Carvedilol - Beta Blocker

  • Carvedilol is classified as a beta-adrenergic blocking agent (beta blocker) 1
  • It blocks both beta-1 and beta-2 receptors and has additional alpha-blocking properties 1
  • It's particularly useful in patients with hypertension and heart failure 1
  • It's among the top prescribed antihypertensive medications in the US and EU 1

6. Verapamil - Non-dihydropyridine Calcium Channel Blocker

  • Verapamil belongs to the non-dihydropyridine subclass of calcium channel blockers 1
  • Unlike dihydropyridines, it has significant effects on cardiac conduction 1
  • Available in immediate-release and extended-release formulations 1
  • It should be avoided in combination with beta blockers except in specific circumstances like atrial fibrillation rate control 1

Clinical Considerations

  • Thiazide-type diuretics like chlorthalidone are often recommended as first-line therapy for most hypertensive patients 1
  • ACE inhibitors and ARBs should not be used in combination due to increased risk of adverse effects without additional benefit 1
  • In Black patients with hypertension, thiazide diuretics and calcium channel blockers are more effective than ACE inhibitors or ARBs 1
  • Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) have more pronounced effects on heart rate and cardiac conduction than dihydropyridine agents 1
  • Most patients with hypertension require two or more medications from different classes to achieve blood pressure control 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.